Table 5 Cumulative incidence and incidence rate of non-cuSCC among patients with metastatic melanomaa
Outcome | Event, n | Cumulative Incidenceb (95 % CI) | Incidence Rateb (95 % CI) |
|---|---|---|---|
Within 30 d after the index date | 0 | -- | -- |
Within 60 d after the index date | 2 | 0.1 (0.02-0.2) | 4.6 (1.1-18.2) |
Within 90 d after the index date | 2 | 0.1 (0.02-0.2) | 3.1 (0.8-12.5) |
Within 180 d after the index date | 3 | 0.1 (0.03-0.3) | 2.5 (0.8-7.8) |
Within 270 d after the index date | 3 | 0.1 (0.03-0.3) | 1.8 (0.6-5.6) |
Within 365 d after the index date | 3 | 0.1 (0.03-0.3) | 1.4 (0.5-4.4) |
Ever post index date | 3 | 0.1 (0.03-0.3) | 0.4 (0.1-1.3) |